{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Acides lévuliniques : Questions médicales les plus fréquentes",
"headline": "Acides lévuliniques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Acides lévuliniques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-12",
"dateModified": "2025-05-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Acides lévuliniques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cétoacides",
"url": "https://questionsmedicales.fr/mesh/D007651",
"about": {
"@type": "MedicalCondition",
"name": "Cétoacides",
"code": {
"@type": "MedicalCode",
"code": "D007651",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.241.755"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Acides lévuliniques",
"alternateName": "Levulinic Acids",
"code": {
"@type": "MedicalCode",
"code": "D007982",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kyoungseon Min",
"url": "https://questionsmedicales.fr/author/Kyoungseon%20Min",
"affiliation": {
"@type": "Organization",
"name": "Gwangju Clean Energy Research Center, Korea Institute of Energy Research (KIER), Gwangju 61003, Republic of Korea. Electronic address: min4605@kier.re.kr."
}
},
{
"@type": "Person",
"name": "Zhihao Yu",
"url": "https://questionsmedicales.fr/author/Zhihao%20Yu",
"affiliation": {
"@type": "Organization",
"name": "School of Environmental Science and Engineering, Tianjin Key Laboratory of Biomass/Wastes Utilization, Tianjin University, Tianjin, 300350, P. R. China."
}
},
{
"@type": "Person",
"name": "Xuebin Lu",
"url": "https://questionsmedicales.fr/author/Xuebin%20Lu",
"affiliation": {
"@type": "Organization",
"name": "School of Environmental Science and Engineering, Tianjin Key Laboratory of Biomass/Wastes Utilization, Tianjin University, Tianjin, 300350, P. R. China."
}
},
{
"@type": "Person",
"name": "Jian Xiong",
"url": "https://questionsmedicales.fr/author/Jian%20Xiong",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry & Environmental Science, School of Science, Tibet University, Lhasa, 850000, P. R. China."
}
},
{
"@type": "Person",
"name": "Na Ji",
"url": "https://questionsmedicales.fr/author/Na%20Ji",
"affiliation": {
"@type": "Organization",
"name": "School of Environmental Science and Engineering, Tianjin Key Laboratory of Biomass/Wastes Utilization, Tianjin University, Tianjin, 300350, P. R. China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37511475",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241411715"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36894035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.gastro.2023.02.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.",
"datePublished": "2023-02-28",
"url": "https://questionsmedicales.fr/article/36855007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12350-023-03202-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optimal age to stop prostate cancer screening and early detection.",
"datePublished": "2023-08-19",
"url": "https://questionsmedicales.fr/article/37598870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcpo.2023.100443"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.",
"datePublished": "2022-10-03",
"url": "https://questionsmedicales.fr/article/36121650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijc.34298"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides carboxyliques",
"item": "https://questionsmedicales.fr/mesh/D002264"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cétoacides",
"item": "https://questionsmedicales.fr/mesh/D007651"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acides lévuliniques",
"item": "https://questionsmedicales.fr/mesh/D007982"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Acides lévuliniques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Acides lévuliniques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Acides lévuliniques",
"description": "Comment diagnostiquer une intoxication aux acides lévuliniques ?\nQuels tests sont utilisés pour détecter les acides lévuliniques ?\nQuels symptômes indiquent une exposition aux acides lévuliniques ?\nY a-t-il des marqueurs biologiques pour les acides lévuliniques ?\nLes tests d'imagerie sont-ils utiles pour les acides lévuliniques ?",
"url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Early+Detection+of+Cancer&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Acides lévuliniques",
"description": "Quels sont les symptômes courants d'une exposition ?\nLes acides lévuliniques provoquent-ils des allergies ?\nY a-t-il des effets à long terme d'une exposition ?\nLes symptômes varient-ils selon la dose ?\nLes enfants sont-ils plus sensibles aux acides lévuliniques ?",
"url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Early+Detection+of+Cancer&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Acides lévuliniques",
"description": "Comment prévenir l'exposition aux acides lévuliniques ?\nLes travailleurs doivent-ils être formés ?\nDes équipements de protection sont-ils nécessaires ?\nY a-t-il des réglementations sur leur utilisation ?\nLes fuites doivent-elles être signalées ?",
"url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Early+Detection+of+Cancer&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Acides lévuliniques",
"description": "Quel est le traitement principal pour l'intoxication ?\nDes antidotes existent-ils pour les acides lévuliniques ?\nComment traiter les irritations cutanées causées ?\nLes soins d'urgence sont-ils nécessaires ?\nLa détoxification est-elle recommandée ?",
"url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Early+Detection+of+Cancer&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Acides lévuliniques",
"description": "Quelles complications peuvent survenir après exposition ?\nLes complications sont-elles réversibles ?\nY a-t-il des risques de cancer liés aux acides lévuliniques ?\nLes complications peuvent-elles affecter la santé mentale ?\nDes soins de suivi sont-ils nécessaires après exposition ?",
"url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Early+Detection+of+Cancer&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Acides lévuliniques",
"description": "Qui est le plus à risque d'exposition ?\nL'âge influence-t-il la sensibilité ?\nLes personnes allergiques sont-elles plus à risque ?\nY a-t-il des prédispositions génétiques ?\nLes conditions de santé préexistantes augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Early+Detection+of+Cancer&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux acides lévuliniques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les acides lévuliniques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour mesurer les niveaux d'acides."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux acides lévuliniques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des nausées, des vertiges et des douleurs abdominales peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques pour les acides lévuliniques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de marqueurs biologiques spécifiques pour ces acides."
}
},
{
"@type": "Question",
"name": "Les tests d'imagerie sont-ils utiles pour les acides lévuliniques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'imagerie ne sont généralement pas utilisés pour diagnostiquer l'exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une exposition ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées et des irritations cutanées."
}
},
{
"@type": "Question",
"name": "Les acides lévuliniques provoquent-ils des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent développer des réactions allergiques à ces acides."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme d'une exposition ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des problèmes respiratoires et cutanés."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la dose ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus sensibles aux acides lévuliniques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques de ces acides."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux acides lévuliniques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les produits contenant des acides lévuliniques et portez des équipements de protection."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et la manipulation sécurisée est essentielle pour les travailleurs."
}
},
{
"@type": "Question",
"name": "Des équipements de protection sont-ils nécessaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des gants et des masques doivent être portés lors de la manipulation de ces acides."
}
},
{
"@type": "Question",
"name": "Y a-t-il des réglementations sur leur utilisation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réglementations strictes encadrent l'utilisation des acides lévuliniques dans l'industrie."
}
},
{
"@type": "Question",
"name": "Les fuites doivent-elles être signalées ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, toute fuite ou déversement doit être signalé immédiatement aux autorités compétentes."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour l'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste principalement à éliminer l'exposition et à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les acides lévuliniques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique pour l'intoxication aux acides lévuliniques."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les irritations cutanées peuvent être traitées avec des crèmes apaisantes et des antihistaminiques."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins d'urgence peuvent être nécessaires en cas de symptômes graves ou persistants."
}
},
{
"@type": "Question",
"name": "La détoxification est-elle recommandée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La détoxification n'est généralement pas nécessaire, mais une surveillance médicale est conseillée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des troubles respiratoires ou des dermatites peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La plupart des complications sont réversibles avec un traitement approprié et rapide."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer liés aux acides lévuliniques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de preuves concluantes liant ces acides à un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications physiques peuvent entraîner des effets sur la santé mentale, comme l'anxiété."
}
},
{
"@type": "Question",
"name": "Des soins de suivi sont-ils nécessaires après exposition ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical est recommandé pour surveiller d'éventuelles complications tardives."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique sont les plus à risque d'exposition aux acides."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la sensibilité ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus sensibles aux effets toxiques."
}
},
{
"@type": "Question",
"name": "Les personnes allergiques sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents d'allergies peuvent être plus sensibles aux acides."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines prédispositions génétiques peuvent influencer la sensibilité aux toxines."
}
},
{
"@type": "Question",
"name": "Les conditions de santé préexistantes augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme l'asthme ou des maladies cutanées peuvent augmenter le risque."
}
}
]
}
]
}
The central objective of the metamorphosis of discovery science into biomedical applications is to serve the purpose of patients and curtail the global disease burden. The journey from the discovery o...
Diagnosing gastric cancer (GC) while the disease remains eligible for surgical resection is challenging. In view of this clinical challenge, novel and robust biomarkers for early detection thus improv...
The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastro...
In discovery phase, one LR (GClnc1) was found to be up-regulated in both tissue and circulating EV samples with an area under the curve (AUC) of 0.9369 (95% confidence interval [CI], 0.9073-0.9664) fo...
EV-derived GClnc1 serves as a circulating biomarker for the early detection of GC, thus providing opportunities for curative surgery and improved survival outcomes....
Cancer therapy-induced cardiotoxicity is an emerging clinical and healthcare issue. Myocardial dysfunction and heart failure are mostly responsible for increased cardiovascular mortality in cancer dis...
Prostate Cancer screening should be discontinued at older ages because competing mortality risks eventually dominate the risk of Prostate Cancer and harms exceed benefits. We explored the Prostate Can...
We applied Bellman Equations to formulate the net benefits biopsy and "do nothing". Using difference between the net benefits of two alternatives, we calculated the stopping age. The cancer states wer...
Our results suggested that Prostate Cancer screening stopping ages from the patient, healthcare system, and social were 70, 68, and 68 respectively. The univariate sensitivity analysis showed that the...
Men should not be screened for Prostate Cancer beyond 70 years old, as this results in the net benefit of "do nothing" above the biopsy. Nevertheless, this finding needs to be further studied with mor...
Colorectal cancer (CRC) develops mainly from colorectal advanced adenomas (AA), which are considered precancerous lesions. Novel early diagnostic biomarkers are urgently needed to distinguish CRC and ...
The modality to detect ovarian cancer at an early stage is very limited. Early diagnosis determines the prognosis. This study aimed to develop a risk assessment tool for early detection of ovarian can...
This study was carried out as a cohort study of patients diagnosed with suspected ovarian tumors undergoing cytoreduction operation at Hasan Sadikin Hospital, Bandung, from December 2019 to September ...
In total, 115 patients included in this study. The differences were statistically significant in terms of the six variables (abdominal bloating, nausea/vomiting, decreased of appetite, fullness, menst...
Risk assessments based on ovarian cancer self-assessment unfortunately were not comparable to postoperative histopathology as a single predictor. Ten variables in ovarian cancer artificial intelligenc...
Early detection of colorectal cancer (CRC) significantly enhances patient outcomes. Conventional CRC screening tools, like endoscopy and stool-based tests, have constraints due to their invasiveness o...
In this research, we harnessed the Mutation Capsule Plus (MCP) technology to profile an array of genomic characteristics from cfDNA procured from a single blood draw. This profiling encompassed DNA me...
This model was subsequently validated in another cohort comprising 89 CRC patients and 95 healthy controls. Remarkably, the model achieved an area under the curve (AUC) of 0.981 (95% confidence interv...
Our findings underscore the clinical potential of our multiomics liquid biopsy test, indicating its prospective role as a noninvasive method for early-stage CRC detection. This multiomics approach hol...
Clinical diagnostics rely heavily on the detection and quantification of cancer biomarkers. The rapid detection of cancer-specific biomarkers is of great importance in the early diagnosis of cancers a...
A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. ...
Hepatocellular carcinoma (HCC) is the fastest-rising and fourth most common cause of cancer death worldwide. Liver cirrhosis is the largest underlying risk factor for HCC. Therefore, patients with cir...
This is a UK-based prospective, longitudinal, diagnostic, prognostic, multicentre, non-CTIMP study. Aiming to recruit 3000 patients with liver cirrhosis without a HCC diagnosis, the Pearl cohort will ...
Ethical approval has been granted by REC and the trial is registered on ClinicalTrials.gov. The results will be published in peer-reviewed journals and presented at relevant meetings....
NCT05541601....